Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.07% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CRBU · Jun 30, 2026
Caribou Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001619856-26-000055General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1520.15% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-43.79% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-1690.39% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1263.64% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
165.24% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20255/6 normalizedLevel 3Jun 30, 20255/6 normalizedLevel 3Sep 30, 20255/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20266/6 normalizedLevel 3Jun 30, 20266/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 3.00%
- Current
- 0.07%
- Delta
- -2.94%
- Previous
- -1125.74%
- Current
- -1520.15%
- Delta
- -394.41%
- Previous
- 1.87%
- Current
- -43.79%
- Delta
- -45.66%
- Previous
- -1096.37%
- Current
- -1690.39%
- Delta
- -594.02%
- Previous
- 859.87%
- Current
- 1263.64%
- Delta
- 403.78%
- Previous
- 98.33%
- Current
- 165.24%
- Delta
- 66.91%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Biological Products, (No Diagnostic Substances) peers →Has State · Caribou Biosciences, Inc. →Transitioned To · CRBU Fundamental State →Transitioned To · CRBU CAPEX_INTENSITY_DECREASED →Transitioned To · CRBU CASH_GENERATION_DECREASED →Transitioned To · CRBU GROWTH_DECREASED →Transitioned To · CRBU PROFITABILITY_DECREASED →Transitioned To · CRBU R_AND_D_INTENSITY_INCREASED →Transitioned To · CRBU SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.